NCT06734793 Wearable Electronic Breath Sound Sensing Device
| NCT ID | NCT06734793 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Asthma in Children |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-02-26 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2025-02-26 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will assess the ability of a wearable stethoscope to monitor wheezing in high-risk asthma patients admitted at Children's Healthcare of Atlanta. This study is important to assist in the health management of patients with chronic lung diseases that can experience exacerbations leading to their health worsening and requiring hospitalization. The population that will be approached for this study will include 10 pediatric subjects hospitalized at Children's Healthcare of Atlanta for an asthma-related exacerbation. Participants will wear the patches for up to 8 hours on their chest and back wall from their date of consent until their hospital discharge. This may range from the participant taking part in 1 to 14 visits that could last up to 8 hours.
Eligibility Criteria
Inclusion Criteria: * Age 6-17 years * Diagnosis of persistent asthma * Being treated for an acute asthma exacerbation * Parent can speak and understand English Exclusion Criteria: * Unable to provide consent for the study * History of prematurity * History of other chronic lung conditions - cystic fibrosis, bronchiectasis, or primary ciliary dyskinesia * History of latex allergy or allergy to medical tape adhesive * Patients currently using another medical device - implanted pacemaker or vagal nerve stimulator or diaphragm pacing device
Contact & Investigator
Lokesh Guglani, MD
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT06734793 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Asthma in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06734793 currently recruiting?
Yes, NCT06734793 is actively recruiting participants. Contact the research team at lokesh.guglani@emory.edu for enrollment information.
Where is the NCT06734793 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT06734793 clinical trial?
NCT06734793 is sponsored by Emory University. The principal investigator is Lokesh Guglani, MD at Emory University. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.